Luis Carlos Saiz, Javier Gorricho, Javier Garjón, Maria Concepción Salaya, Juan Erviti, Leire LeacheKey messagesThe evidence identified in this review does not support lower blood pressure goals over standard goals in people with high blood pressure (also known as hypertension) and heart or vascular (blood vessels and circulatory system) problems...

Eduard Shantsila, Monika Kozieł-Siołkowska, Gregory LipReview questionWe reviewed the evidence that examined whether antiplatelet agents reduced total deaths or major thrombotic events or both in patients with elevated blood pressure (BP) when compared to placebo or other active treatment. We also assessed whether oral anticoagulants reduced total...

Cochrane Hypertension publishes a quarterly newsletter with updates on our systematic reviews, training, and other editorial team activities and news. Subscribe to the Cochrane HTN newsletter.Our latest newsletter (Spring 2022) is now availableIf you have feedback on current or past newsletters, or suggestions for future newsletter topics,...

Plain language conclusions:BackgroundHypertension or elevated blood pressure is a major risk factor for cardiovascular diseases, such as coronary heart disease, stroke, and heart failure. Lowering blood pressure to normal levels is effective in reducing the risks of these diseases. Many of the risk factors relating to hypertension, such as...